James H. Boone

1.8k total citations
47 papers, 1.3k citations indexed

About

James H. Boone is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, James H. Boone has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 17 papers in Genetics and 16 papers in Epidemiology. Recurrent topics in James H. Boone's work include Infant Nutrition and Health (16 papers), Microscopic Colitis (16 papers) and Inflammatory Bowel Disease (15 papers). James H. Boone is often cited by papers focused on Infant Nutrition and Health (16 papers), Microscopic Colitis (16 papers) and Inflammatory Bowel Disease (15 papers). James H. Boone collaborates with scholars based in United States, Germany and Italy. James H. Boone's co-authors include David M. Lyerly, Paul A. Rufo, Stephen B. Hanauer, Sunanda V. Kane, William J. Sandborn, Robert J. Carman, Anna Zholudev, Michael Camilleri, Andrew C. Barnes and Mara Lawniczak and has published in prestigious journals such as Gastroenterology, Trends in Ecology & Evolution and Journal of Clinical Microbiology.

In The Last Decade

James H. Boone

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James H. Boone United States 17 546 475 397 313 267 47 1.3k
Catherine S. Williams United States 19 250 0.5× 390 0.8× 278 0.7× 233 0.7× 860 3.2× 42 1.6k
Timoleon Rallis Greece 21 220 0.4× 231 0.5× 316 0.8× 405 1.3× 40 0.1× 76 1.4k
John Croese Australia 27 144 0.3× 213 0.4× 657 1.7× 676 2.2× 212 0.8× 55 2.9k
Maaike Stoel Netherlands 9 250 0.5× 195 0.4× 193 0.5× 525 1.7× 176 0.7× 10 2.2k
Caroline Mansfield Australia 25 300 0.5× 196 0.4× 599 1.5× 217 0.7× 58 0.2× 87 1.6k
L. C. Archard United Kingdom 27 406 0.7× 903 1.9× 185 0.5× 461 1.5× 29 0.1× 65 2.8k
Christine Bruce United Kingdom 19 198 0.4× 592 1.2× 206 0.5× 568 1.8× 90 0.3× 49 1.6k
Máire Conrad United States 14 339 0.6× 246 0.5× 153 0.4× 118 0.4× 52 0.2× 34 902
William Horsnell South Africa 24 102 0.2× 223 0.5× 175 0.4× 297 0.9× 80 0.3× 65 1.5k
Vanessa L. Hale United States 16 101 0.2× 161 0.3× 71 0.2× 394 1.3× 82 0.3× 31 1.3k

Countries citing papers authored by James H. Boone

Since Specialization
Citations

This map shows the geographic impact of James H. Boone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Boone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Boone more than expected).

Fields of papers citing papers by James H. Boone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Boone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Boone. The network helps show where James H. Boone may publish in the future.

Co-authorship network of co-authors of James H. Boone

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Boone. A scholar is included among the top collaborators of James H. Boone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Boone. James H. Boone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tucker, Erika M., Julie M. Allen, Vijay Barve, et al.. (2023). Building a community-based taxonomic resource for digitization of parasites and their hosts. Insect Systematics and Diversity. 7(6).
2.
Roth, Sophie, Philipp Jung, James H. Boone, et al.. (2022). Antigen-Specific vs. Neutralizing Antibodies Against Conditioned Media of Patients With Clostridioides difficile Infection: A Prospective Exploratory Study. Frontiers in Microbiology. 13. 859037–859037.
3.
4.
Gray, James M., et al.. (2020). Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature. Inflammatory Intestinal Diseases. 5(3). 151–158. 1 indexed citations
5.
Desai, Meeta, et al.. (2020). Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 32(9). 1099–1105. 1 indexed citations
6.
Gray, James M., et al.. (2019). Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease. World Journal of Gastrointestinal Pathophysiology. 10(5). 54–63. 14 indexed citations
7.
8.
Carman, Robert J., et al.. (2018). Multidrug resistant Clostridium difficile ribotype 027 in southwestern Virginia, 2007 to 2013. Anaerobe. 52. 16–21. 8 indexed citations
9.
Tang, Vivian, et al.. (2016). Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients. Journal of Pediatric Gastroenterology and Nutrition. 64(2). 248–253. 5 indexed citations
10.
Buderus, Stephan, James H. Boone, & Michael J. Lentze. (2015). Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD. Gastroenterology Research and Practice. 2015. 1–4. 22 indexed citations
11.
Boone, James H., Laurie Archbald‐Pannone, Robert J. Carman, et al.. (2014). Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality. European Journal of Clinical Microbiology & Infectious Diseases. 33(6). 1045–1051. 23 indexed citations
12.
Archbald‐Pannone, Laurie, James H. Boone, Robert J. Carman, David M. Lyerly, & Richard L. Guerrant. (2014). Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. Journal of Hospital Infection. 88(4). 218–221. 16 indexed citations
13.
Boone, James H., et al.. (2013). Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection. European Journal of Clinical Microbiology & Infectious Diseases. 32(12). 1517–1523. 31 indexed citations
14.
Tang, Linda, Hui Cai, Udayakumar Navaneethan, et al.. (2012). Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn’s disease-like condition of the pouch. International Journal of Colorectal Disease. 27(11). 1455–1463. 11 indexed citations
15.
Pfefferkorn, Marian D., et al.. (2010). Utility of Fecal Lactoferrin in Identifying Crohn Disease Activity in Children. Journal of Pediatric Gastroenterology and Nutrition. 51(4). 425–428. 28 indexed citations
16.
Tang, Linda, et al.. (2008). Clinical significance of stool ASCA in disorders of the Ileal Pouch. Inflammatory Bowel Diseases. 14. S2–S2. 4 indexed citations
17.
Howard, Michael D., James H. Boone, Virginia Buechner‐Maxwell, Gerhardt G. Schurig, & Thomas J. Inzana. (2004). Inhibition of bovine macrophage and polymorphonuclear leukocyte superoxide anion production by Haemophilus somnus. Microbial Pathogenesis. 37(5). 263–271. 15 indexed citations
18.
Buderus, Stephan, James H. Boone, David M. Lyerly, & Michael J. Lentze. (2004). Fecal Lactoferrin: A New Parameter to Monitor Infliximab Therapy. Digestive Diseases and Sciences. 49(6). 1036–1039. 63 indexed citations
19.
Walker, Thomas R., et al.. (2003). FECAL LACTOFERRIN MEASUREMENTS ARE USEFUL IN THE INTERVAL ASSESSMENT OF PATIENTS WITH ACTIVE AND INACTIVE INFLAMMATORY BOWEL DISEASE. The American Journal of Gastroenterology. 98. S246–S246. 2 indexed citations
20.
Kane, Sunanda V., William J. Sandborn, Paul A. Rufo, et al.. (2003). Fecal Lactoferrin Is A Sensitive and Specific Marker in Identifying Intestinal Inflammation. The American Journal of Gastroenterology. 98(6). 1309–1314. 287 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine S. Williams Breakdown of academic impact, for papers by Timoleon Rallis Breakdown of academic impact, for papers by John Croese Breakdown of academic impact, for papers by Maaike Stoel Breakdown of academic impact, for papers by Caroline Mansfield Breakdown of academic impact, for papers by L. C. Archard Breakdown of academic impact, for papers by Christine Bruce Breakdown of academic impact, for papers by Máire Conrad Breakdown of academic impact, for papers by William Horsnell Breakdown of academic impact, for papers by Vanessa L. Hale
Rankless by CCL
2026